Company Data

Aligos Therapeutics Inc.

Ticker
ALGS
Current Price
$5.5 -3%
Market Cap
$33.6M
Price Target
Refer to Report
Volume
76.0K
52wk Range
$3.76 - $46.8
Advanced Market Data

Overview

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company’s pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy